Sunday June 16, 2019

Common Drug Form Effective in Treating Children With Anxiety Disorder

The findings confirm the American Academy of Child and Adolescent Psychiatry's recommendations that SSRIs should be considered as the first-line of medication treatment for anxiety in youth, Strawn noted

0
//
Probiotics Not Effective in Reducing Anxiety: Study
Anxiety linked to kicking, yelling during sleep: Study. Pixabay

Researchers have found that selective serotonin reuptake inhibitors (SSRIs) are very effective in treating children and adolescents with paediatric anxiety disorder.

They reached the conclusion after examining common medications prescribed for children and adolescents with anxiety disorders.

SSRIs are the most commonly prescribed anti-depressants, which can ease symptoms of moderate to severe depression and cause fewer side effects compared with other anti-depressants.

Symptoms of anxiety include recurring fears, aversions to social situations as well as being unable to control worries. It could manifest into troubled sleep, difficulty in concentrating, and heart and digestive issues.

According to the American Academy of Paediatrics (AAP), anxiety disorders are the most common type of mental health disorder in children.

“Clinicians have limited data to help them select from among the evidence-based treatments for patients with anxiety. This meta-analysis provides guidance in terms of medication-specific differences in efficacy and tolerability among medications, commonly used to treat pediatric patients with anxiety disorders,” said Jeffrey Strawn, Associate Professor at the University of Cincinnati in the US.

Victimization in early school days leads to anxiety. Pixabay
Victimization in early school days can also leads to anxiety. Pixabay

“Our study synthesises evidences from multiple trials to guide clinicians and patients in deciding which medication to go for while treating children and adolescents with anxiety disorders,” said Eric Dobson, psychiatry resident at the Medical University of South Carolina in Charleston.

For the study, researchers studied 2,623 patients, aged 11 and a half years on average. Patients with social anxiety disorders with moderate severity were randomly assigned to receive medication or placebo and had .

The results, published in the Journal of Clinical Psychiatry, showed among anxious youth treatment response was more effective with SSRIs than with serotonin-norepineprhine reuptake inhibitors (SNRIs).

Also Read- Risk of Cervical Cancer Highest in Middle-aged Indian Women

While SSRIs were the most tolerable class of medication, tricyclic antidepressants were the least tolerable, findings revealed.

“This comprehensive evaluation comparing efficacy and tolerability of treatments in pediatric anxiety disorders suggests that SSRIs are superior to SNRIs and all other classes of medications,” said Dobson.

The findings confirm the American Academy of Child and Adolescent Psychiatry’s recommendations that SSRIs should be considered as the first-line of medication treatment for anxiety in youth, Strawn noted. (IANS)

Next Story

Super Drug to Take on Stubborn Tuberculosis in Uttar Pradesh, India

Another pill with bedaquiline has already been introduced in the state to fight excessively drug resistant (XDR) TB

0
Drug, Tuberculosis, Uttar Pradesh
The new anti-TB drug, with delamanid as active substance, is currently administered to patients. Pixabay

Uttar Pradesh may soon get a new drug to fight the multi-drug resistant (MDR) tuberculosis (TB).

The new anti-TB drug, with delamanid as active substance, is currently administered to patients — primarily children in the age group of six to 17 years — in a few southern states of India and is yet to be introduced in Uttar Pradesh, which reported 4.22 lakh patients in 2018.

According to the State TB officer Santosh Gupta, “Delamanid would be introduced in UP in the third quarter of the year, as per the central guidelines.”

“We are awaiting procurement of the drug from the union government. Four of our officers have been trained for implementation of it, which will be given to children (9-17 years) with MDR-TB,” the doctor added.

Drug, Tuberculosis, Uttar Pradesh
Uttar Pradesh may soon get a new drug to fight the multi-drug resistant (MDR) tuberculosis (TB). Pixabay

Gupta said that another pill with bedaquiline has already been introduced in the state to fight excessively drug resistant (XDR) TB and for which 18 nodal drug resistance centres have been set up.

“An XDR-TB patient is resistant to all anti-TB drugs, including even the stronger combinations of medicines. It is an advanced form of MDR-TB. Bedaquiline, which is WHO recommended, has been made available to patients for free and is found to be effective,” said Gupta and added that patients were being kept under close observation for side effects.

He further laid emphasis on the early detection of TB cases.

Also Read- Chandrayaan-2 will be Launched on July 15, Land on Moon on Sept 6/7

Meanwhile, chairman of the UP state task force for TB control and head of KGMU’s respiratory medicine department, Professor Suryakant said: “Around 28 lakh TB patients are recorded in India. If nutrition is not received in the form of lentils/pulses, fruits and vegetables in diet, a person is more susceptible to the TB bacteria.” (IANS)